Well are in the frame so to speakMerck keeps deal focus with Keytruda patent cliff on horizon
The company is open to acquisitions of up to $15 billion, company CEO Rob Davis said Thursday on a fourth quarter earnings call.
Full Article
https://www.biopharmadive.com/news/merck-dealmaking-15-billion-keytruda-cliff-davis/706309/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202024-02-07%20BioPharma%20Dive:%20Commercialization%20%5Bissue:58939%5D&utm_term=BioPharma%20Dive:%20Commercialization
Well are in the frame so to speak Merck keeps deal focus with...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
-0.005(6.10%) |
Mkt cap ! $563.6M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.3¢ | 7.6¢ | $1.931M | 24.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1392733 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 140950 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
-0.005 ( 6.71 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.3¢ | 7.6¢ | 9515046 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| IMU (ASX) Chart |